H

Hurel Corporation

8 employees

HμREL, a bioanalytic tools firm, researches, develops and commercializes products and services based on 3D cell-based tissue constructs.

Basic info

biotechnology

Medical Device

Biotechnology

diagnostic microfluidic tools

ADME

3D cultures

co-cultures

IVIVC

in vitro toxicity

organs under flow

Clinical Trials

hepatocytes

organ-on-chip

drug discovery

Education

Contract research

drug metabolism

organs-on-chip

cell cultures

microfluidics

Life Science

2006

$9.2M

from 1 investors over 1 rounds

H

Hurel Corporation raised $9.2M on April 3, 2013

Investors: Spring Mountain Capital